Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 420-425

  Jongerius, Ilse ^a   Puister, Manon ^a   Wu, Jin ^b   Ruyken, Maartje ^a   Van Strijp, Jos A G ^a   Rooijakkers, Suzan H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT INHIBITOR; STAPHYLOCOCCAL COMPLEMENT INHIBITOR; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; COMPLEMENT COMPONENT C3; STAPHYLOCOCCAL DECOMPLEMENTATION ANTIGEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BINDING AFFINITY; CHO CELL; COMPLEMENT CLASSICAL PATHWAY; DIMERIZATION; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STAPHYLOCOCCUS AUREUS; ANIMAL; CHEMISTRY; CRICETULUS; HAMSTER; HUMAN; IMMUNOLOGY; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIGENS, BACTERIAL; CHO CELLS; COMPLEMENT C3; COMPLEMENT C3-C5 CONVERTASES; CRICETINAE; CRICETULUS; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; PHAGOCYTOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 73949087351     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902865     Document Type: Article

References (35)

1. Kirkitadze, M. D., and P. N. Barlow. 2001. Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol. Rev. 180: 146-161.
2. Walport, M. J. 2001. Complement. Second of two parts. N. Engl. J. Med. 344: 1140-1144.
3. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344: 1058-1066.
4. Fujita, T., M. Matsushita, and Y. Endo. 2004. The lectin-complement pathway-its role in innate immunity and evolution. Immunol. Rev. 198: 185-202.
5. Gasque, P. 2004. Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41: 1089-1098.
6. Xu, Y., S. V. Narayana, and J. E. Volanakis. 2001. Structural biology of the alternative pathway convertase. Immunol. Rev. 180: 123-135.
7. Janssen, B. J., E. G. Huizinga, H. C. Raaijmakers, A. Roos, M. R. Daha, K. Nilsson-Ekdahl, B. Nilsson, and P. Gros. 2005. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437: 505-511.
8. Janssen, B. J., A. Christodoulidou, A. McCarthy, J. D. Lambris, and P. Gros. 2006. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444: 213-216.
9. Pangburn, M. K., and N. Rawal. 2002. Structure and function of complement C5 convertase enzymes. Biochem. Soc. Trans. 30: 1006-1010.
10. Rawal, N., and M. K. Pangburn. 2003. Formation of high affinity C5 convertase of the classical pathway of complement. J. Biol. Chem. 278: 38476-38483.
11. Ehlers, M. R. 2000. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect. 2: 289-294.
12. Helmy, K. Y., K. J. Katschke, Jr., N. N. Gorgani, N. M. Kljavin, J. M. Elliott, L. Diehl, S. J. Scales, N. Ghilardi, and M. van Lookeren Campagne. 2006. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124: 915-927.
13. Kim, D. D., and W. C. Song. 2006. Membrane complement regulatory proteins. Clin. Immunol. 118: 127-136.
14. Lambris, J. D., Z. Lao, T. J. Oglesby, J. P. Atkinson, C. E. Hack, and J. D. Becherer. 1996. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. J. Immunol. 156: 4821-4832.
15. Oran, A. E., and D. E. Isenman. 1999. Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35). J. Biol. Chem. 274: 5120-5130. (Pubitemid 129501534)
16. Wiesmann, C., K. J. Katschke, J. Yin, K. Y. Helmy, M. Steffek, W. J. Fairbrother, S. A. McCallum, L. Embuscado, L. DeForge, P. E. Hass, et al. 2006. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444: 217-220.
17. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
18. Geisbrecht, B. V. 2008. Staphylococcal complement inhibitors: biological functions, recognition of complement components, and potential therapeutic implications. Adv. Exp. Med. Biol. 632: 221-236.
19. Rooijakkers, S. H., K. P. van Kessel, and J. A. van Strijp. 2005. Staphylococcal innate immune evasion. Trends Microbiol. 13: 596-601.
20. Rooijakkers, S. H., M. Ruyken, A. Roos, M. R. Daha, J. S. Presanis, R. B. Sim, W. J. van Wamel, K. P. van Kessel, and J. A. van Strijp. 2005. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat. Immunol. 6: 920-927.
21. Rooijakkers, S. H., J. Wu, M. Ruyken, R. van Domselaar, K. L. Planken, A. Tzekou, D. Ricklin, J. D. Lambris, B. J. Janssen, J. A. van Strijp, et al. 2009. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat. Immunol. 10: 721-727.
22. Nickells, M., R. Hauhart, M. Krych, V. B. Subramanian, K. Geoghegan-Barek, H. C. Marsh, Jr., and J. P. Atkinson. 1998. Mapping epitopes for 20 monoclonal antibodies to CR1. Clin. Exp. Immunol. 112: 27-33.
23. Veldkamp, K. E., K. P. Van Kessel, J. Verhoef, and J. A. Van Strijp. 1997. Staphylococcal culture supernates stimulate human phagocytes. Inflammation 21: 541-551.
24. Větvicka, V., W. Reed, M. L. Hoover, and G. D. Ross. 1993. Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. J. Immunol. 150: 4052-4060.
25. Hale, J. E. 1995. Irreversible, oriented immobilization of antibodies to cobaltiminodiacetate resin for use as immunoaffinity media. Anal. Biochem. 231: 46-49.
26. Foster, T. J. 2004. The Staphylococcus aureus "superbug". J. Clin. Invest. 114: 1693-1696.
27. Rooijakkers, S. H., W. J. van Wamel, M. Ruyken, K. P. van Kessel, and J. A. van Strijp. 2005. Anti-opsonic properties of staphylokinase. Microbes Infect. 7: 476-484.
28. Jongerius, I., J. Köhl, M. K. Pandey, M. Ruyken, K. P. van Kessel, J. A. van Strijp, and S. H. Rooijakkers. 2007. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 204: 2461-2471.
29. Langley, R., B. Wines, N. Willoughby, I. Basu, T. Proft, and J. D. Fraser. 2005. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc α RI binding and serum killing of bacteria. J. Immunol. 174: 2926-2933. (Pubitemid 40279711)
30. van Wamel, W. J., S. H. Rooijakkers, M. Ruyken, K. P. van Kessel, and J. A. van Strijp. 2006. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on β-hemolysin-converting bacteriophages. J. Bacteriol. 188: 1310-1315.
31. Ricklin, D., A. Tzekou, B. L. Garcia, M. Hammel, W. J. McWhorter, G. Sfyroera, Y. Q. Wu, V. M. Holers, A. P. Herbert, P. N. Barlow, et al. 2009. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family. J. Immunol. 183: 2565-2574.
32. Taniguchi-Sidle, A., and D. E. Isenman. 1994. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 α′-chain. J. Immunol. 153: 5285-5302. (Pubitemid 24983929)
33. Wu, J., Y. Q. Wu, D. Ricklin, B. J. Janssen, J. D. Lambris, and P. Gros. 2009. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat. Immunol. 10: 728-733.
34. Burman, J. D., E. Leung, K. L. Atkins, M. N. O'Seaghdha, L. Lango, P. Bernadó, S. Bagby, D. I. Svergun, T. J. Foster, D. E. Isenman, et al. 2008. Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J. Biol. Chem. 283: 17579-17593.
35. Ricklin, D., S. K. Ricklin-Lichtsteiner, M. M. Markiewski, B. V. Geisbrecht, and J. D. Lambris. 2008. Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2. J. Immunol. 181: 7463-7467.